Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression

被引:64
作者
Thomas, FT
Ricordi, C
Contreras, JL
Hubbard, WJ
Jiang, XL
Eckhoff, DE
Cartner, S
Bilbao, G
Neville, DM
Thomas, JM
机构
[1] Univ Alabama, Dept Surg, Div Transplantat Immunol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Comparat Med, Birmingham, AL 35294 USA
[3] Univ Alabama, Gene Therapy Program, Birmingham, AL 35294 USA
[4] Univ Miami, Diabet Res Inst, Miami, FL 33136 USA
[5] NIMH, Mol Biol Lab, Bethesda, MD 20800 USA
关键词
D O I
10.1097/00007890-199903270-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Isolated pancreatic islet transplantation (IPITx) is an attractive alternative for treatment of insulin-dependent diabetes mellitus (IDDM). How-ever, IPITx has been difficult to implement clinically because islets frequently fail to function, have a high incidence of rejection, and are susceptible to autoimmune recurrence and damage by chronic immunosuppressive therapy. Tolerance induction may be a rational approach to resolve several of these limitations. Because anti-CD3 immunotoxin (IT) has been successful in promoting stable primate kidney transplant tolerance in our experience, we considered that tolerance induction with IT might be duplicated in IPITx. Materials and Methods. Three monkeys with spontaneous IDDM (two Macaca fascicularis and one Ceropithecus aethiops) were treated with xenogeneic pancreatic islets (Macaca mulatta). Intrahepatic islet transplantation was performed at a mean of 13136+/-3860 islet equivalents/kg. Islet xenograft acceptance was accomplished by tolerance induction with two injections of IT given on day 0 at 2 hr before transplantation and on day +1, respectively. IT treatment was supplemented with cyclosporine and steroids administered on days 0 through 4. No additional immunosuppression was given thereafter. Two additional control macaques with spontaneous IDDM received the immunosuppressive protocol without islet infusion. Results, All recipients were restored to stable euglycemia, off exogenous insulin, within 1-2 weeks after transplantation. Glucose tolerance, C-peptide, and glycosylated hemoglobin tests confirmed the restoration of normal glucose homeostasis after islet transplantation. All three islet recipients have remained euglycemic at 410, 255, and 100 days of follow-up despite recovery of peripheral T cells to normal levels. In contrast, none of the controls presented changes in the diabetic status 4 and 8 months after treatment. Conclusions. These results represent the first demonstration in nonhuman primates of stable, long-term acceptance of nonencapsulated xenogeneic islets off all immunosuppression, suggesting operational tolerance. The findings have potential implications for islet transplantation as well as improved and more cost-effective therapy for IDDM.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 36 条
[1]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[2]  
BALLINGER WF, 1972, SURGERY, V72, P175
[3]   NONHUMAN PRIMATE MODELS OF ATHEROSCLEROSIS - POTENTIAL FOR THE STUDY OF DIABETES-MELLITUS AND HYPERINSULINEMIA [J].
CLARKSON, TB ;
KORITNIK, DR ;
WEINGAND, KW ;
MILLER, LC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (12) :51-59
[4]   RETRACTED: Peritransplant tolerance induction with anti-CD3-immunotoxin - A matter of proinflammatory cytokine control (Retracted article. See vol 85, pg. 920, 2008) [J].
Contreras, JL ;
Wang, PX ;
Eckhoff, DE ;
Lobashevsky, AL ;
Asiedu, C ;
Frenette, L ;
Robbin, ML ;
Hubbard, WJ ;
Cartner, S ;
Nadler, S ;
Cook, WJ ;
Sharff, J ;
Shiloach, J ;
Thomas, FT ;
Neville, DM ;
Thomas, JM .
TRANSPLANTATION, 1998, 65 (09) :1159-1169
[5]  
COSIMI AB, 1990, SURGERY, V108, P406
[6]   The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival2 [J].
Gjertson, DW ;
Cecka, JM ;
Terasaki, PI .
TRANSPLANTATION, 1995, 60 (12) :1384-1388
[7]   HETEROGENEITY OF INSULIN RESPONSES - PHASES LEADING TO TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS IN THE RHESUS-MONKEY [J].
HANSEN, BC ;
BODKIN, NL .
DIABETOLOGIA, 1986, 29 (10) :713-719
[8]  
HERING BJ, 1994, TRANSPLANT P, V26, P565
[9]   ATHEROSCLEROSIS AND INSULIN IN PRIMATES WITH DIABETES-MELLITUS [J].
HOWARD, CF .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (12) :60-69
[10]  
HU H, 1997, CELL IMMUNOL, V117, P26